Interesting Case Review

Slides:



Advertisements
Similar presentations
Multivessel PCI procedure complicated with fracture of the wire Marcin D ę binski, MD Head: Pawel E. Buszman, MD, FACC University Hospital of Silesia,
Advertisements

 An angiographic tool grading the complexity of coronary artery disease  A semiquantitative visual score that will help us to be aware of the anatomical.
ISAR-LEFT MAIN 2 Randomized Trial Zotarolimus- vs. Everolimus-Eluting Stents for Treatment of Unprotected Left Main Coronary Artery Lesions Julinda Mehilli,
29th ANNUAL SCIENTIFIC SESSIONS – SCA&I
Francesco Liistro Cardiovascular Department, Arezzo, Italy Impact of Thrombus Aspiration on Myocardial Tissue Reperfusion and Left Ventricular Functional.
Call for CASES Staged PCI in a patient with multivessel coronary disease disqualified from CABG. Pawel Buszman, MD, FESC, FSCAI Marcin Debinski, MD Krzysztof.
Chaim Lotan MD, Yaron Almagor MD, Karel Kuiper MD, M.J. Suttorp MD, William Wijns MD The SICTO Study CYPHER TM Sirolimus-eluting stent in Chronic Total.
5F in 6F (7F) technique in DES era (Parent-child catheter technique)
Subacute Occlusion at distal Edge of Stent Beijing Anzhen Hospital Capital Medical University Wu, Xiaofan.
Unstable angina and arterial hypertension Leszek Kinasz, MD American Heart of Poland Ustron, Poland.
VULNERABLE PLAQUES: Pertinent doubts and solutions in interventional cardiology EuroPCR Paris, 16 May 2006.
Server Stenosis of LCX Orifice and bad stenting final result : Short Period follow-up(6Ms) People’s Hospital of Zhengzhou Universty, PR China ( 河南省人民医院.
IVUS evaluation TAP technology for unprotected left main bifurcation lesions interventional therapy Yong-Sheng Ke. MD Department of Cardiology, Yijishan.
Featuring CTO Complex-PCI by Trans-radial Approach CTO Case review 5 French TRI CTO of right coronary artery -5 F Launcher guiding Catheter (right Judkins.
Shanghai Jiaotong University
Treatment of bifurcation lesions is a complex problem Different techniques are commonly used (Y-/T-stenting, „culotte“ technique, „kissing stent“ technique…)
The First Affiliated Hospital of Harbin Medical University
Using a deflectable tipped Catheter to treat previously inaccessible lesions Helen Routledge Interventional Fellow Institut Cardiovasculaire Paris Sud.
PCI from native vessel disease or bypass vessel disease post CABG Nanjing first hospital Yefei Chenshaoliang.
Chronic Total Occlusions
Date of download: 6/2/2016 Copyright © The American College of Cardiology. All rights reserved. From: Retrograde Techniques and the Impact of Operator.
End points in PTCA trials. A successful angioplasty is defined as the reduction of a minimum stenosis diameter to
Revascularization Strategy: Syntax Score and Beyond
Gerald S. Werner, MD, FESC, FACC, FSCAI Klinikum Darmstadt GmbH
Interesting-Didactic Cases
A new technique of IVUS guided CTO PCI
Adel Gamal, MD and Mohamed Saber, Msc
Cangrelor Case Presentations
Takashi Ashikaga,MD,PhD
Nightmares in the Cath Lab
Transradial Intervention: Complex Case Review Yes, They Can Be Done!
Multi Modality Approach to Diagnosis of Ischemia in Post CABG Cases
Interesting Case Presentation
Advanced CTO Techniques:
A strange post-CABG presentation
Use of Laser When the Balloon Cannot Cross
Clinical Presentation
Solaci at EuroPCR. Complex left main PCI Patient presentation
The Spectrum of Guidewires Available to Recanalize CTO and How to Choose the Wire/Device Hybrid CTO PCI 2011 Craig A. Thompson, M.D., MMSc. Director, Invasive.
The Radial Approach for CTO PCI Utility in the Retrograde and the Antegrade Approaches Shigeru Saito, MD, FACC, FSCAI, FJCC Shonan Kamakura General Hospital.
Kansas City, Missouri, USA
Meruzhan Saghatelyan, MD, Interventional cardiologist
9:00 AM-9:05 AM, Tuesday, Oct. 31; Room 201/203
BVS Expand: First Results of Wide Clinical Applications
Complex PCI to CTO lesion in RCA with nightmares complications
Crescendo angina in Distal Left Main CTO
The XIENCE V EXCEED Study
PCI in patients with cardiogenic shock associated with acute occlusion of the left main coronary artery.
Subintimal Tracking and Reentry for CTO STAR Method
How to Build Your Own CTO PCI Program
Case Presentation CRT Sumith Aleti.
The Hybrid approach to CTO PCI
Essesntials for CTO Recanalization
Newer methods to Facilitate the Retrograde Approach
Fig. 2. Revascularization for CTO in RCA
Using Coronary CTA to Guide Intervention for CTO
The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery: The SYNTAX Study One Year Results of the PCI and CABG Registries.
Incidence and management of restenosis after treatment of unprotected left main disease with drug-eluting stents: 70 restenotic cases from a cohort of.
12-month clinical and 13-month angiographic outcomes from a randomized trial evaluating the Absorb Bioresorbable Vascular Scaffold vs. metallic drug-eluting.
The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery: The SYNTAX Study One Year Results of the PCI and CABG Registries.
Presented at TCT 2006.
Impact of Diabetes Mellitus on Long-term Outcomes in the
Patient Examples of CMR Stress Test in Women Patient #1 is a 70-year-old, post-menopausal woman with typical angina and 3 coronary artery disease (CAD)
ISAR-LEFT MAIN: A Randomized Clinical Trial on Drug-Eluting Stents for Unprotected Left Main Lesions J. Mehilli, MD Deutsches Herzzentrum Technische.
ISAR-LEFT MAIN: A Randomized Clinical Trial on Drug-Eluting Stents for Unprotected Left Main Lesions J. Mehilli, MD Deutsches Herzzentrum Technische.
Ahmed A. Khattab, MD For the German Cypher Registry Investigators
ISAR-LEFT MAIN 2 Randomized Trial Zotarolimus- vs
DISTAL CORONARY ARTERY DISEASE
ISAR-LEFT MAIN 2 Randomized Trial Zotarolimus- vs
DISTAL CORONARY ARTERY DISEASE
Presentation transcript:

Interesting Case Review Gerald S. Werner, MD PhD Klinikum Darmstadt Darmstadt, Germany

Gerald S. Werner, MD, PhD I have no real or apparent conflicts of interest to report.

PCI – CTO of the RCA Female T.N. Age 62

CTO of the RCA Female, T.N., 62 Diagnosis 3-vessel disease - CTO of RCA - Subtotal occlusion of the LCX - Multiple stenosis of LAD branches Risk factors Diabetes mellitus Typ1 (for 40 years) Ex-smoker

Clinical presentation typical chest pain during climbing of stairs and shortness of breath during activity ECG ST-depression and negative T in V5 & V6

Non-invasive evaluation Echo: Hypokinesia basal wall, LV function <50% Stress-ECG: 150 W significant ST changes MRI perfusionscan EF 41% Hypokinesia lateral and inferolateral, anterior and septal inferolateral ischemia Subendocardial late enhancement in the territory of all vessels (25-50% in various territories)

Laboratory investigations Hb = 12,5 g/dl Creatinine = 0,8mg/dl Creatinine clearance = 77 ml/min Cholesterol (total) = 192 mg/dl HDL = 91 mg/dl LDL = 69 mg/dl on therapy HBA1c 6,4% CK 371 U/l Troponin I <0,04 ng/ml

Baseline Angiogram

Baseline Angiogram

Baseline Angiogram

Baseline Angiogram

Risk evaluation EuroSCORE (mortality logistic) = 2,25% Syntax score = 19 Surgeon declined CABG because of poor peripheral targets

Key issues / Strategy PCI of RCA as most important territory and most difficult lesion LCX as secondary territory, but with proven ischemia

Key issues / Technique Difficult identification of RCA occlusion site on diagnostic angio The potential of MSCT coregistration for the planning of the technical approach

MSCT “parallel“ viewing

MSCT: Orthogonal roadmap

Material Guide: AR1 SH 7Fr (Launcher, Medtronic)

Identifiying the entry

Where is the CTO, and how long ? No calcium at proximal cap and side branch, but at distal cap.

Material Guide: AR1 SH 7Fr (Launcher, Medtronic) Microcatheter: Finecross (Terumo) Initial wire: Fielder XT (ASAHI Intecc)

Even a Fielder XT can penetrate a cap A Fielder XT is NOT a 30s wire

Gradual advancement of Fielder XT

Verified distal intraluminal position

Material used Guide: AR1 SH 7Fr (Launcher, Medtronic) Microcatheter: Finecross (Terumo) Initial wire: Fielder XT (ASAHI Intecc) Balloon: MiniTrek 1.2 X 12 (Abbott Vascular) Anchoring: BMW wire + Maverick 2 x 15 mm

Difficulties in balloon passage: anchoring

Post dilatation

After 2 Xience stents

Material used Guide: AR1 SH 7Fr (Launcher, Medtronic) Microcatheter: Finecross (Terumo) Initial wire: Fielder XT (ASAHI Intecc) Balloon: MiniTrek 1.2 X 12 (Abbott Vascular) Anchoring: BMW wire + Maverick 2 x 15 mm Predilatation: Maverick 2.5 X 30 mm (BSC) DES: Xience Prime LL 2.5 X 38 + 2.5 X 12 (Abbott Vascular)

Procedural details Lab time: 134 min (taped case recording) Fluoro time: 37.9 min Contrast volume: 230 ml Precautions: 500 ml NaCl infusion during procedure

An interesting case because … … demonstrates the need for careful angio analysis …, assisted by additional MSCT visualization MSCT demystified the CTO in this case A Fielder XT does not need “microchannels“ to work well Anchoring is a basic and cheap technique